CYP17A1
Reactivité: Humain
WB
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
ELISA (1:64000) Western Blot (0.1-0.3 μg/mL) Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) (3-5 μg/mL) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
In 0.5 mg/mL Tris saline, pH 7.3 (0.02 % sodium azide, 0.5 % BSA)
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Store at -20°C. Aliquot to avoid repeated freezing and thawing.
Ohnishi, Ogawa, Saibara, Nishioka, Kariya, Fukumoto, Onishi, Yoshida: "CYP17 polymorphism as a risk factor of tamoxifen-induced hepatic steatosis in breast cancer patients." dans: Oncology reports, Vol. 13, Issue 3, pp. 485-9, (2005) (PubMed).
Antigène
CYP17A1
(Cytochrome P450, Family 17, Subfamily A, Polypeptide 1 (CYP17A1))